Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms
FEMS Microbiology Reviews · 01.01.2020 · 44 (1) · 123-153
DOI: 10.1093/femsre/fuz030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEMS Microbiology Reviews, online erschienen am 16.12.2019. Verfasst von Lloyd S Miller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunology, Janssen Research and Development, 1400 McKean Road, Spring House, PA, 19477, USA. Hauptthemen laut MEDLINE: Staphylococcus aureus. Die Arbeit wurde bisher 232-mal zitiert (Crossref) und nennt 325 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Invasive Staphylococcus aureus infections are a leading cause of morbidity and mortality in both hospital and community settings, especially with the widespread emergence of virulent and multi-drug resistant methicillin-resistant S. aureus strains. There is an urgent and unmet clinical need for non-antibiotic immune-based approaches to treat these infections as the increasing antibiotic resistance is creating a serious threat to public health. However, all vaccination attempts aimed at preventing S. aureus invasive infections have failed in human trials, especially all vaccines aimed at generating high titers of opsonic antibodies against S. aureus surface antigens to facilitate antibody-mediated bacterial clearance. In this review, we summarize the data from humans regarding the immune responses that protect against invasive S. aureus infections as well as host genetic factors and bacterial evasion mechanisms, which are important to consider for the future development of effective and successful vaccines and immunotherapies against invasive S. aureus infections in humans. The evidence presented form the basis for a hypothesis that staphylococcal toxins (including superantigens and pore-forming toxins) are important virulence factors, and targeting the neutralization of these toxins are more likely to provide a therapeutic benefit in contrast to prior vaccine attempts to generate antibodies to facilitate opsonophagocytosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology, Janssen Research and Development, 1400 McKean Road, Spring House, PA, 19477, USA.
- Department of Dermatology, Johns Hopkins University School of Medicine, 1550 Orleans Street, Cancer Research Building 2, Suite 209, Baltimore, MD, 21231, USA.
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 1830 East Monument Street, Baltimore, MD, 21287, USA.
- Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD, 21287, USA.
- Department of Materials Science and Engineering, Johns Hopkins University, 3400 North Charles Street, Baltimore, MD, 21218, USA.
- Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, 315 Trent Drive, Hanes House, Durham, NC, 27710, USA.
Förderung
- NIAMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Miller, L. S., Fowler, V. G., Shukla, S. K., Rose, W. E., & Proctor, R. A. (2020). Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiology Reviews, 44(1), 123-153. https://doi.org/10.1093/femsre/fuz030
Vancouver
Miller LS, Fowler VG, Shukla SK, Rose WE, Proctor RA. Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiology Reviews. 2020;44(1):123-153. doi:10.1093/femsre/fuz030
BibTeX
@article{Miller2020,
author = {Miller, Lloyd S and Fowler, Vance G and Shukla, Sanjay K and Rose, Warren E and Proctor, Richard A},
title = {Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms},
journal = {FEMS Microbiology Reviews},
year = {2020},
volume = {44},
number = {1},
pages = {123--153},
doi = {10.1093/femsre/fuz030}
}
EUVIMED